Speaker illustration

Doctor Eduard Sidelnkov

Amgen (Europe) GmbH, Rotkreuz (Switzerland)

A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom

Event: ESC Congress 2020

Topic: Public Health

Session: Cardiovascular Disease Prevention and Treatment: What Drives Change?


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb